Shorted
Inoviq logo
IIQ

Inoviq

Health Care Equipment & Services

Inoviq is an Australian biotechnology company focused on developing and commercializing innovative cancer diagnostic products. The company's focus is on improving cancer detection and monitoring through its proprietary technologies. Inoviq aims to address unmet needs in cancer diagnostics, offering potential benefits for patients and healthcare providers.

Short position

short percentage0.00%
reported shorts27
shares on issue140.775M

Inoviq (ASX:IIQ) has 0.00% of its shares on issue reported as short positions as of 5 Oct 2026, or about 27 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.58% in October 2025. IIQ is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

Inoviq (IIQ) News

Latest articles and price-sensitive announcements with AI sentiment classification.

Kalkine
Neutral
4d ago

What is next for INOVIQ after its ovarian cancer test review?

Highlights INOVIQ has outlined a defined pathway to commercialise its EXO-OC ovarian cancer test as a US laboratory developed test. An independent technical review supported the companys assessment of why its earlier verification study could not be completed. The company plans clinical verification using standardised sample collection, followed by laboratory validation with a US partner. INOVIQ (ASX:IIQ) has reset the path for its EXO-OC ovarian cancer diagnostic, publishing a commercialisati...

Continue reading